AZTA - azenta.com Operating income before deduction of amortization

Graphic logo of azenta.com (AZTA)

Azenta, Inc. (AZTA) is recognized as an impeccable custodian of biomaterials trusted by the largest pharmaceutical behemoths. The EBITDA financial metric visualizes this status through cash flows, where the latest parameter stands at 39.98. The company dominates cryogenic storage automation, creating the infrastructure for personalized medicine. Growth is based on unique robotic genomic sample retrieval systems that are critical for the development of new drugs.

AZTA Brooks Automation Operating profit before deduction of amortization (11/23/2025 - 11/10/2026)

Azenta (AZTA) - metric breakdowns and financial figures

- current price and projected stock value:
Price Brooks Automation|AZTA - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Azenta|AZTA - Enterprise Value
- balance sheet equity data:
Accounting Value per Share Azenta|AZTA - Company Net Assets|Market Value to Book Value azenta.com|AZTA - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Azenta, Inc.|AZTA - Long-Term Debt to Capital|Current Liabilities to Capital Azenta Inc|AZTA - Company Aggregate Debts|Debt to Book Value Ratio Azenta|AZTA - Company Long-Term Debts|Short-Term Debt Volume Azenta|Quick Liquidity Indicator azenta.com
- earnings and multiples data:
AZTA - Net Profit|Projected Future Earnings Azenta, Inc.|AZTA - Price to Earnings Ratio|Future Price to Earnings azenta.com|AZTA - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Azenta|AZTA - Operating profit EBITDA|Net earnings per one share for the last twelve months Azenta|AZTA - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year azenta.com|AZTA - Net earnings per share growth this year|Earnings growth forecast for next year Azenta, Inc.
Summary company analytics:Brooks Automation - AZTA
Mass-produced product of Azenta, Inc.

Steady demand from biolabs and institutes is reflected in EBITDA fluctuations, confirming the effectiveness of the Azenta, Inc. (AZTA) commercial model. This metric measures actual cash flow from core operations before depreciation and taxes. The calculation is based on the sum of operating profit and non-cash asset write-downs. Rising values signal high business resilience; however, buying at local peaks on the chart creates the risk of overpaying for the asset.

Who Azenta, Inc. competes with

Company profit before taxes, interest and amortization ABT (Abbott Corp.)|Thermo Fisher Scientific - Operating profit EBITDA|Operating income before deduction of amortization gehealthcare.com GEHC|MTD: Operating profit EBITDA|Operating profit before deduction of amortization Waters Corp|Operating profit before deduction of amortization TECH|BRKR: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Varex Imaging (VREX)|Operating profit before deduction of amortization semlerscientific.com SMLR|Operating profit EBITDA BFLY (Butterfly Network)|Mesa Laboratories Inc (MLAB) - Profit before interest, taxes and amortization|Quantum-Si Corp - Operating profit EBITDA|NNOX (Nano-X Imaging Ltd) - Operating profit before amortization|QTRX: Operating profit EBITDA|MASS - Operating income before deduction of amortization|CV (CapsoVision, Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization MaxCyte Inc. (MXCT)|Operating profit EBITDA RPID|Operating profit EBITDA Seer Bio (SEER)|Profit before payment of interest, taxes and amortization Hyperfine, Inc. HYPR|fonar.com - Profit before payment of interest, taxes and amortization|DXR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization MDAI (spectral-ai.com)|VIVS: Operating profit EBITDA|Profit before interest, taxes and amortization Aclarion Corporation (ACON)|Profit before payment of interest, taxes and amortization Akoya Biosciences Inc|THMO - Operating profit before depreciation charges|Operating profit before deduction of amortization TLIS (Talis Biomedical)|Operating profit EBITDA T2 Biosystems Inc. (TTOO)